Physician Resource Center
![](http://55933-bcmed.s3.amazonaws.com/bcp/branded/css/rop/webcast_4_9_24/rop_028631_event_homepage_banner_1300x150_od.png)
Specialties
Featured Content View More
Watch: When to Think of Amyloidosis, How to Diagnose and Treat
Experts from Roswell Park Comprehensive Cancer Center joined with colleagues from the Boston University School of Medicine to discuss the latest information on amyloidosis, including recommendations for physicians on how to diagnose the ...
Meet the Team: Hamza Hassan, MD
Hamza Hassan, MD, thinks the future is bright for patients with Myeloma and Amyloidosis. With encouraging research and treatment development opportunities, he moved from Boston to Buffalo to join the team at Roswell Park Comprehensive ...
Career Opportunity: Join Our Roswell Park Team
Roswell Park is currently seeking an accomplished leader to serve as the Clinical Chief for Thoracic Medical Oncology to spearhead patient care, research, and education advancements.
Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
Region’s only Comprehensive Cancer Center earns maximum rating, marking five decades of consecutive NCI support.
Study Reveals Worse Clinical Outcomes in Breast Cancer Patients Who Reported Higher Pain and Stress
Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and ...
A team of researchers from Roswell Park Comprehensive Cancer Center, report that the efficacy of doxorubicin, a widely used chemotherapy drug, was enhanced in preclinical lymphoma models when it was combined with propranolol.
Featured CMEs
This site is intended for healthcare professionals
Roswell Park News
Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024
Wednesday, July 24, 2024 9:58 AM
Roswell Park Appoints 5 New Leaders Overseeing Key Areas of Patient Care and Support
Thursday, June 27, 2024 3:41 PM
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park
Friday, June 21, 2024 9:43 AM